摘要 |
<p>Compounds of Formula I are useful for the treatment of anxiety disorders such as generalized anxiety disorder (GAD), panic attack, post traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD) and social phobias. wherein: A is chosen from: aryl or heteroaryl, A being optionally substituted with up to 5 independently-selected groups R<SUP>8</SUP>; R<SUP>1</SUP> is chosen from: alkyl or haloalkyl; R<SUP>2</SUP> is chosen from: H, C(O)R<SUP>6</SUP>, C(O)OR<SUP>6</SUP>, SO2R<SUP>6 </SUP>or C(O)NR<SUP>6</SUP>R<SUP>7</SUP>; R<SUP>3</SUP>, R<SUP>4</SUP> and R<SUP>5</SUP> are independently chosen from: H or alkyl; R<SUP>6</SUP>and R<SUP>7</SUP> are independently chosen from: H or alkyl; and R<SUP>8</SUP> is chosen from: OH, CN, halo, alkyl, alkoxy, haloalkyl, haloalkoxy, C(O)R<SUP>6</SUP>, C(O)OR<SUP>6</SUP>, SO2R<SUP>6</SUP> or C(O)NR<SUP>6</SUP>R<SUP>7</SUP>.</p> |
申请人 |
NPS PHARMACEUTICALS, INC.;HIGGINS, GUY;SLASSI, ABDELMALIK;ISAAC, METHVIN |
发明人 |
HIGGINS, GUY;SLASSI, ABDELMALIK;ISAAC, METHVIN |